Post Graduate Department of Ophthalmology, INHS Asvini, Colaba Mumbai, Maharashtra, India.
Indian J Ophthalmol. 2021 Mar;69(3):765-767. doi: 10.4103/ijo.IJO_1464_20.
Pseudophakic cystoid macular edema (PCME) is one of the leading causes of reduced vision, after cataract surgery. Topical steroids and nonsteroidal anti-inflammatory drops are frequently used in the management; however, intravitreal injections may be required for chronic cases. Suprachoroidal injection of preservative free Triamcinolone acetonide is a recent addition to the therapeutic armamentarium of ophthalmologists for treatment of cystoid macular edema of varied etiology. Though the drug is commercially available at a reasonable cost, the microneedle is not commonly available. We modified a 26 G needle for safe and cost-effective delivery of preservative-free suprachoroidal triamcinolone acetonide (SCT). In the current series of three patients with non-resolving PCME, macular edema resolved and vision improved over 3 months.
后发性白内障囊样水肿(PCME)是白内障手术后视力下降的主要原因之一。皮质类固醇和非甾体抗炎滴眼剂常用于治疗,但对于慢性病例可能需要玻璃体腔内注射。眼内注射无防腐剂的曲安奈德是眼科医生治疗各种病因的囊样黄斑水肿的最新治疗方法。虽然该药物在合理的成本下可在商业上获得,但微针并不常见。我们为安全和经济有效地输送无防腐剂的玻璃体内曲安奈德(SCT),对 26G 针进行了改良。在目前的三例非持续性 PCME 患者中,3 个月后黄斑水肿消退,视力改善。